Financials in USD. Standardized financial statements.
A compact view of how Molecular Data Inc. turns revenue into operating income and net income.
| Metric | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Revenue? | $7.60B | $13.25B | $9.05B | $4.20B | $3.21B |
| Revenue Growth? | -42.7% | +46.3% | +115.5% | +31.1% | 0.0% |
| Cost of Revenue? | $7.61B | $13.14B | $8.97B | $4.15B | $3.18B |
| Gross Profit? | -$10.20M | $103.01M | $80.17M | $50.23M | $26.12M |
| Gross Margin? | -0.1% | +0.8% | +0.9% | +1.2% | +0.8% |
| Operating Expenses? | $321.36M | $292.99M | $315.96M | $139.97M | $131.89M |
| Operating Income? | -$331.56M | -$189.97M | -$235.79M | -$91.18M | -$105.77M |
| EBITDA? | -$313.13M | -$185.67M | -$233.15M | -$89.49M | -$104.52M |
| Income Before Tax | -$325.58M | -$193.12M | -$254.64M | -$107.81M | -$113.94M |
| Income Tax Expense | $2.46M | $430,000 | $0 | $17.58M | $0 |
| Net Income? | -$328.04M | -$193.55M | -$254.64M | -$107.81M | -$113.94M |
| EPS? | $-42.40 | $-27.71 | $-33.20 | $-14.06 | $-14.86 |
| Diluted EPS? | $-42.30 | $-27.71 | $-33.20 | $-14.06 | $-14.86 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality